90 related articles for article (PubMed ID: 2287063)
41. [Leukemia and pre-DIC--coagulation and fibrinolytic parameters in severe infection at the nadir of leukocyte after chemotherapy].
Saito M; Asakura H; Jokaji H; Uotani C; Kumabashiri I; Morishita E; Yamazaki M; Matsuda T
Rinsho Byori; 1990 Jul; Suppl 86():158-63. PubMed ID: 2232237
[No Abstract] [Full Text] [Related]
42. Localization of tissue plasminogen activator on experimental thrombi in rats.
Kimata H; Nakajima K; Koide T; Yamamoto S; Kondo S
J Pharmacobiodyn; 1990 Dec; 13(12):751-9. PubMed ID: 2129128
[TBL] [Abstract][Full Text] [Related]
43. Comparative study of the fibrinolytic system in human fetuses and in pregnant women.
Reverdiau-Moalic P; Gruel Y; Delahousse B; Rupin A; Huart MC; Body G; Leroy J
Thromb Res; 1991 Mar; 61(5-6):489-99. PubMed ID: 2028451
[TBL] [Abstract][Full Text] [Related]
44. Elevated tissue factor levels in leukemic cell homogenate.
Nakasaki T; Wada H; Watanabe R; Mori Y; Gabazza EC; Kageyama S; Nishikawa M; Shiku H
Clin Appl Thromb Hemost; 2000 Jan; 6(1):14-7. PubMed ID: 10726043
[TBL] [Abstract][Full Text] [Related]
45. [Effect of normal and leukemic leukocytes on blood coagulation and fibrinolysis].
Hiller E
Fortschr Med; 1978 Jun; 96(22):1181-4. PubMed ID: 658868
[TBL] [Abstract][Full Text] [Related]
46. Plasminogen activator inhibitor-2 in patients with monocytic leukemia.
Scherrer A; Kruithof EK; Grob JP
Leukemia; 1991 Jun; 5(6):479-86. PubMed ID: 2056772
[TBL] [Abstract][Full Text] [Related]
47. Plasminogen-dependent fibrinolytic activity in normal human lymphocytes: diminished lymphocyte plasminogen activator in chronic lymphocytic leukemia.
Zucker S; Mehling K; Rai K
Am J Hematol; 1985 Aug; 19(4):373-86. PubMed ID: 3927713
[TBL] [Abstract][Full Text] [Related]
48. Fibrinolytic balance and lupus anticoagulant in patients with repeated spontaneous fetal loss.
Ferro D; Violi F; Quintarelli C; Sebastianelli A; D'Amelio R; Zichella L; Balsano F
BMJ; 1992 Aug; 305(6852):504-5. PubMed ID: 1392996
[No Abstract] [Full Text] [Related]
49. Hypofibrinogenemia due to increased fibrinolysis in two patients with acute promyelocytic leukemia.
Chan TK; Chan GT; Chan V
Aust N Z J Med; 1984 Jun; 14(3):245-9. PubMed ID: 6594115
[TBL] [Abstract][Full Text] [Related]
50. High frequency of plasminogen activator secretion by malignant human lymphoid cell lines of T-cell type origin.
Venuat AM; Soria C; Soria J; Krief P; Mirshahi M; He L; Thomaidis A; Houllier A; Billard M; Boucheix C
Cancer; 1988 Nov; 62(9):1952-7. PubMed ID: 3167807
[TBL] [Abstract][Full Text] [Related]
51. The expression of tissue factor antigen and activity on the surface of leukemic cells.
Tanaka M; Yamanishi H
Leuk Res; 1993 Feb; 17(2):103-11. PubMed ID: 8429686
[TBL] [Abstract][Full Text] [Related]
52. Prediction of disseminated intravascular coagulation in patients with leukemia.
Naitoh M; Andoh K; Sadakata H; Tanaka H; Kobayashi N
Intern Med; 1994 Mar; 33(3):131-5. PubMed ID: 8061387
[TBL] [Abstract][Full Text] [Related]
53. The role of tissue thromboplastin in the development of DIC accompanying neoplastic diseases.
Gonmori H; Maekawa T; Kobayashi N; Tanaka H; Tsukada H; Takada M; Andou K
Bibl Haematol; 1983; (49):23-39. PubMed ID: 6667248
[TBL] [Abstract][Full Text] [Related]
54. Fibrinolytic activity in depression and neurosis.
Pietraszek MH; Takada Y; Nishimoto M; Ohara K; Ohara K; Takada A
Thromb Res; 1991 Sep; 63(6):661-6. PubMed ID: 1780810
[No Abstract] [Full Text] [Related]
55. Potential role of interleukin-1 as the trigger for diffuse intravascular coagulation in acute nonlymphoblastic leukemia.
Cozzolino F; Torcia M; Miliani A; Carossino AM; Giordani R; Cinotti S; Filimberti E; Saccardi R; Bernabei P; Guidi G
Am J Med; 1988 Feb; 84(2):240-50. PubMed ID: 3261536
[TBL] [Abstract][Full Text] [Related]
56. [A method for determining plasminogen with a Russian chromogenic substrate and its diagnostic significance].
Momot AP; Mamaev AN; Barkagan ZS; Nevedrova OE; Makarov VA; Voiushina TL; Erin DN
Klin Lab Diagn; 2000 Mar; (3):21-4. PubMed ID: 10878927
[TBL] [Abstract][Full Text] [Related]
57. Hypofibrinogenemia and disseminated intravascular coagulation rarely complicate treatment-naïve acute lymphoblastic leukemia.
Gaulin C; Chan A; Derkach A; Park JH; Mantha S; Geyer MB; Tallman MS
Leuk Lymphoma; 2020 Oct; 61(10):2497-2501. PubMed ID: 32420774
[No Abstract] [Full Text] [Related]
58. Comparative studies on fast acting PA-inhibitors from pig and human peripheral leucocytes.
Kopitar M; Drobnic-Kosorok M; Cotic V; Gabrijelcic D; Jerala R; Turk V
Adv Exp Med Biol; 1989; 247B():73-8. PubMed ID: 2514584
[No Abstract] [Full Text] [Related]
59. [Micrometric researches of blood cells in tissue slides from the autopsied leukemic cases].
OKANO K; YOSHINAGA M; DOI K; NAGAI K; TAKAHASHI T; MANABE H
Gan; 1953 Sep; 44(2-3):201-3. PubMed ID: 13128109
[No Abstract] [Full Text] [Related]
60. [Preliminary results of research on the activity of trietylenemelamine (TEM) in vitro on leukemic blood].
VILLA L; POLLI E; SEMENZA G
G Ital Chemioter; 1954; 1(1):98-100. PubMed ID: 13191591
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
